Cargando…

Adult-Like Anti-Mycobacterial T Cell and In Vivo Dendritic Cell Responses Following Neonatal Immunization with Ag85B-ESAT-6 in the IC31® Adjuvant

BACKGROUND: With the exception of some live vaccines, e.g. BCG, subunit vaccines formulated with “classical” adjuvants do not induce similar responses in neonates as in adults. The usual neonatal profile is characterized by lower levels of TH1-associated biomarkers. This has hampered the development...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamath, Arun T., Rochat, Anne-Françoise, Valenti, Mario P., Agger, Else Marie, Lingnau, Karen, Andersen, Peter, Lambert, Paul-Henri, Siegrist, Claire-Anne
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2577009/
https://www.ncbi.nlm.nih.gov/pubmed/18997860
http://dx.doi.org/10.1371/journal.pone.0003683
_version_ 1782160456626995200
author Kamath, Arun T.
Rochat, Anne-Françoise
Valenti, Mario P.
Agger, Else Marie
Lingnau, Karen
Andersen, Peter
Lambert, Paul-Henri
Siegrist, Claire-Anne
author_facet Kamath, Arun T.
Rochat, Anne-Françoise
Valenti, Mario P.
Agger, Else Marie
Lingnau, Karen
Andersen, Peter
Lambert, Paul-Henri
Siegrist, Claire-Anne
author_sort Kamath, Arun T.
collection PubMed
description BACKGROUND: With the exception of some live vaccines, e.g. BCG, subunit vaccines formulated with “classical” adjuvants do not induce similar responses in neonates as in adults. The usual neonatal profile is characterized by lower levels of TH1-associated biomarkers. This has hampered the development of new neonatal vaccines for diseases that require early protection. Tuberculosis is one of the major targets for neonatal immunization. In this study, we assessed the immunogenicity of a novel candidate vaccine comprising a mycobacterial fusion protein, Ag85B-ESAT-6, in a neonatal murine immunization model. METHODS/FINDINGS: The Ag85B-ESAT-6 fusion protein was formulated either with a classical alum based adjuvant or with the novel IC31® adjuvant. Following neonatal or adult immunization, 3 parameters were studied in vivo: (1) CD4(+) T cell responses, (2) vaccine targeting/activation of dendritic cells (DC) and (3) protection in a surrogate mycobacterial challenge model. Conversely to Alum, IC31® induced in both age groups strong Th1 and Th17 responses, characterized by multifunctional T cells expressing IL-2 and TNF-α with or without IFN-γ. In the draining lymph nodes, a similarly small number of DC contained the adjuvant and/or the antigen following neonatal or adult immunization. Expression of CD40, CD80, CD86 and IL-12p40 production was focused on the minute adjuvant-bearing DC population. Again, DC targeting/activation was similar in adults and neonates. These DC/T cell responses resulted in an equivalent reduction of bacterial growth following infection with M. bovis BCG, whereas no protection was observed when Alum was used as adjuvant. CONCLUSION: Neonatal immunization with the IC31®- adjuvanted Ag85B-ESAT-6 subunit vaccine elicited adult-like multifunctional protective anti-mycobacterial T cell responses through the induction of an adult pattern of in vivo DC activation.
format Text
id pubmed-2577009
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-25770092008-11-10 Adult-Like Anti-Mycobacterial T Cell and In Vivo Dendritic Cell Responses Following Neonatal Immunization with Ag85B-ESAT-6 in the IC31® Adjuvant Kamath, Arun T. Rochat, Anne-Françoise Valenti, Mario P. Agger, Else Marie Lingnau, Karen Andersen, Peter Lambert, Paul-Henri Siegrist, Claire-Anne PLoS One Research Article BACKGROUND: With the exception of some live vaccines, e.g. BCG, subunit vaccines formulated with “classical” adjuvants do not induce similar responses in neonates as in adults. The usual neonatal profile is characterized by lower levels of TH1-associated biomarkers. This has hampered the development of new neonatal vaccines for diseases that require early protection. Tuberculosis is one of the major targets for neonatal immunization. In this study, we assessed the immunogenicity of a novel candidate vaccine comprising a mycobacterial fusion protein, Ag85B-ESAT-6, in a neonatal murine immunization model. METHODS/FINDINGS: The Ag85B-ESAT-6 fusion protein was formulated either with a classical alum based adjuvant or with the novel IC31® adjuvant. Following neonatal or adult immunization, 3 parameters were studied in vivo: (1) CD4(+) T cell responses, (2) vaccine targeting/activation of dendritic cells (DC) and (3) protection in a surrogate mycobacterial challenge model. Conversely to Alum, IC31® induced in both age groups strong Th1 and Th17 responses, characterized by multifunctional T cells expressing IL-2 and TNF-α with or without IFN-γ. In the draining lymph nodes, a similarly small number of DC contained the adjuvant and/or the antigen following neonatal or adult immunization. Expression of CD40, CD80, CD86 and IL-12p40 production was focused on the minute adjuvant-bearing DC population. Again, DC targeting/activation was similar in adults and neonates. These DC/T cell responses resulted in an equivalent reduction of bacterial growth following infection with M. bovis BCG, whereas no protection was observed when Alum was used as adjuvant. CONCLUSION: Neonatal immunization with the IC31®- adjuvanted Ag85B-ESAT-6 subunit vaccine elicited adult-like multifunctional protective anti-mycobacterial T cell responses through the induction of an adult pattern of in vivo DC activation. Public Library of Science 2008-11-10 /pmc/articles/PMC2577009/ /pubmed/18997860 http://dx.doi.org/10.1371/journal.pone.0003683 Text en Kamath et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Kamath, Arun T.
Rochat, Anne-Françoise
Valenti, Mario P.
Agger, Else Marie
Lingnau, Karen
Andersen, Peter
Lambert, Paul-Henri
Siegrist, Claire-Anne
Adult-Like Anti-Mycobacterial T Cell and In Vivo Dendritic Cell Responses Following Neonatal Immunization with Ag85B-ESAT-6 in the IC31® Adjuvant
title Adult-Like Anti-Mycobacterial T Cell and In Vivo Dendritic Cell Responses Following Neonatal Immunization with Ag85B-ESAT-6 in the IC31® Adjuvant
title_full Adult-Like Anti-Mycobacterial T Cell and In Vivo Dendritic Cell Responses Following Neonatal Immunization with Ag85B-ESAT-6 in the IC31® Adjuvant
title_fullStr Adult-Like Anti-Mycobacterial T Cell and In Vivo Dendritic Cell Responses Following Neonatal Immunization with Ag85B-ESAT-6 in the IC31® Adjuvant
title_full_unstemmed Adult-Like Anti-Mycobacterial T Cell and In Vivo Dendritic Cell Responses Following Neonatal Immunization with Ag85B-ESAT-6 in the IC31® Adjuvant
title_short Adult-Like Anti-Mycobacterial T Cell and In Vivo Dendritic Cell Responses Following Neonatal Immunization with Ag85B-ESAT-6 in the IC31® Adjuvant
title_sort adult-like anti-mycobacterial t cell and in vivo dendritic cell responses following neonatal immunization with ag85b-esat-6 in the ic31® adjuvant
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2577009/
https://www.ncbi.nlm.nih.gov/pubmed/18997860
http://dx.doi.org/10.1371/journal.pone.0003683
work_keys_str_mv AT kamatharunt adultlikeantimycobacterialtcellandinvivodendriticcellresponsesfollowingneonatalimmunizationwithag85besat6intheic31adjuvant
AT rochatannefrancoise adultlikeantimycobacterialtcellandinvivodendriticcellresponsesfollowingneonatalimmunizationwithag85besat6intheic31adjuvant
AT valentimariop adultlikeantimycobacterialtcellandinvivodendriticcellresponsesfollowingneonatalimmunizationwithag85besat6intheic31adjuvant
AT aggerelsemarie adultlikeantimycobacterialtcellandinvivodendriticcellresponsesfollowingneonatalimmunizationwithag85besat6intheic31adjuvant
AT lingnaukaren adultlikeantimycobacterialtcellandinvivodendriticcellresponsesfollowingneonatalimmunizationwithag85besat6intheic31adjuvant
AT andersenpeter adultlikeantimycobacterialtcellandinvivodendriticcellresponsesfollowingneonatalimmunizationwithag85besat6intheic31adjuvant
AT lambertpaulhenri adultlikeantimycobacterialtcellandinvivodendriticcellresponsesfollowingneonatalimmunizationwithag85besat6intheic31adjuvant
AT siegristclaireanne adultlikeantimycobacterialtcellandinvivodendriticcellresponsesfollowingneonatalimmunizationwithag85besat6intheic31adjuvant